Dong Yi Na, Waxman Elisa A, Lynch David R
Department of Neurology, University of Pennsylvania and the Children's Hospital of Philadelphia, Philadelphia, Pennsylvania 19104-4318, USA.
J Neurosci. 2004 Dec 8;24(49):11035-45. doi: 10.1523/JNEUROSCI.3722-04.2004.
The calcium-dependent protease calpain cleaves the NMDA receptor 2 (NR2) subunit of the NMDA receptor both in vitro and in vivo and thus potentially modulates NMDA receptor function and turnover. We examined the ability of postsynaptic density-95 (PSD-95) protein to alter the calpain-mediated cleavage of NR2A and NR2B. Coexpression of PSD-95 with NMDA receptors in human embryonic kidney 293 cells blocked cleavage of NR2A and NR2B by NMDA receptor-activated calpain. NR2A cleavage by calpain occurred in the cell surface and intracellular fractions and required the presence of NR1 subunits. The blocking effect of PSD-95 did not result from decreased calpain activity, lowered intracellular calcium responses, or the blockade of internalization. Instead, this effect was eliminated by deletion of the C-terminal ESDV motif of NR2A or by overexpression of a palmitoylation-deficient PSD-95 mutant lacking the ability to cluster and to interact with NMDA receptors in situ, suggesting a role for association between the C terminus of NR2A and clustered PSD-95. Synapse-associated protein 102, a membrane-associated guanylate kinase interacting with NR2A but lacking palmitoylation motifs and the ability to cluster, did not protect NR2A from cleavage by calpain. Pharmacological inhibition of palmitoylation disrupted the interaction of PSD-95 with NMDA receptors in cortical neurons and allowed NR2A to be cleaved by calpain, whereas NR2A could not be cleaved in untreated neurons. These results indicate that PSD-95 clustering and direct association of NR2A and PSD-95 mediate the blocking effect of PSD-95 on calpain cleavage. PSD-95 could regulate the susceptibility of NMDA receptors to calpain-mediated cleavage during synaptic transmission and excitotoxicity.
钙依赖性蛋白酶钙蛋白酶在体外和体内均可切割N-甲基-D-天冬氨酸受体(NMDA受体)的NMDA受体2(NR2)亚基,因此可能调节NMDA受体的功能和更新。我们研究了突触后致密蛋白95(PSD-95)改变钙蛋白酶介导的NR2A和NR2B切割的能力。在人胚肾293细胞中,PSD-95与NMDA受体共表达可阻断NMDA受体激活的钙蛋白酶对NR2A和NR2B的切割。钙蛋白酶对NR2A的切割发生在细胞表面和细胞内部分,并且需要NR1亚基的存在。PSD-95的阻断作用并非源于钙蛋白酶活性降低、细胞内钙反应降低或内化阻断。相反,通过缺失NR2A的C末端ESDV基序或通过过表达缺乏原位聚集和与NMDA受体相互作用能力的棕榈酰化缺陷型PSD-95突变体,这种作用被消除,这表明NR2A的C末端与聚集的PSD-95之间的关联发挥了作用。突触相关蛋白102是一种与NR2A相互作用但缺乏棕榈酰化基序和聚集能力的膜相关鸟苷酸激酶,不能保护NR2A免受钙蛋白酶的切割。棕榈酰化的药理学抑制破坏了皮质神经元中PSD-95与NMDA受体的相互作用,并使NR2A被钙蛋白酶切割,而在未处理的神经元中NR2A不能被切割。这些结果表明,PSD-95的聚集以及NR2A与PSD-95的直接关联介导了PSD-95对钙蛋白酶切割的阻断作用。PSD-95可能在突触传递和兴奋性毒性过程中调节NMDA受体对钙蛋白酶介导切割的敏感性。